Jordana Joy

5 days ago | optometrytimes.com | Jordana Joy

In light of the recent US Court of International Trade (CIT) decision to permanently prohibit all tariffs imposed by President Donald Trump under the International Emergency Economic Powers Act (IEEPA), The Vision Council weighed in to access what the decision means for the vision industry.1 With the decision made on May 28, the CIT has given the federal government 10 days to implement a process to halt the collection of IEEPA-related duties, according to a news release.

1 week ago | optometrytimes.com | Mark Bullimore |Jordana Joy

May 31, 2025By Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation. Mark Bullimore, MCOptom, PhD; Erin Tomiyama, OD, PhD; and Prethy Rao, MD, discussed the significance of myopia, emphasizing its role in uncorrectable visual impairment, particularly in the US.

1 week ago | ophthalmologytimes.com | Lori Wright |Jordana Joy

Author(s):,Lori Wright, JD, sat down to talk about a discussion at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice. Editor's note: The below transcript has been lightly edited for clarity. So we spoke about comanagement, generally, between ophthalmologists and optometrists, comanagement of refractive care and comanagement of cataract surgery postop care.

1 week ago | optometrytimes.com | Mitch Ibach |Emily Kaiser Maharjan |Jordana Joy

During his presentation titled "Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition," Mitch Ibach, OD, FAAO, discussed the prevalence of dry eye disease, a significant ocular condition affecting approximately 18 million patients in the United States - 4 times more than those diagnosed with open-angle glaucoma. Ibach emphasized the growing patient awareness and motivation surrounding dry eye, which distinguishes it from other eye conditions like glaucoma.

1 week ago | optometrytimes.com | Jordana Joy

Health artificial intelligence (AI) company Pangaea Data has announced a strategic investment from Topcon Healthcare which aims to accelerate Pangaea’s efforts to address critical care gaps in eye health and systemic disease.1 These efforts include utilizing Pangaea’s clinically validated AI platform PALLUX, according to a news release.